Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_assertion description "[Data from the Cancer and Leukemia Group B 8869/8541 study indicate enhanced dose responsiveness to doxorubicin (Adriamycin) in patients who overexpress the HER2 receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_assertion evidence source_evidence_literature NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_assertion SIO_000772 9563896 NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_assertion wasDerivedFrom befree-20150227 NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_assertion wasGeneratedBy ECO_0000203 NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP378995.RA-xZRQGbJvWgSmLUqVECgqF57kVxvrp8GQBbgx3x4SAs130_provenance.